Skip to content

GI Cancers

EU Focus Meeting 2026


📍 SANA Metropolitan Hotel, R. Soeiro Pereira Gomes 2, 1600-198 Lisbon, Portugal

🗓️ September 11 - 12, 2026


CME Accreditation

MD Education will seek accreditation from the European Accreditation Council for Continuing Medical Education (EACCME). This will allow participants of the academy to earn CME credits, enhancing the educational value of their experience.

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the GI Cancers Focus Meeting 2026, to be held on September 11 - 12, 2026.

Centered around the theme “Updating Knowledge & Clinical Practice in 2026” this meeting provides pivotal collaboration aimed at advancing GI Cancers research and patient treatment.

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.

 

Chairs of GI Cancers Focus Meeting 2026:

Gerald-Prager

Gerald Prager
Medical University of Vienna, Austria

Michel-Ducreux

Michel Ducreux
Gustave Roussy Institute, Villejuif, France


Supporters to be announced...
Interested in supporting this meeting? Get in contact:
alex.worthington@md-education.com

Agenda & Faculty

September 11, 2026 | Day 1  

09:00 AM
Registration Opens

Session I: Pancreas Cancer
Moderated by: Teresa Macarulla

10:05 AM
Systemic Treatment Options in mPDAC

PH

Pascal Hammel
Hôpital Beaujon, Clichy, France
10:25 AM
Targeting RAS
Davide-Melisi-1
Davide Melisi
Medical School and University Hospital,
Verona, Italy
10:45 AM
Neoadjuvant Treatment Concepts in BR- and LA-PDACs
Teresa-Macarulla
Teresa Macarulla
University Hospital Vall d’Hebron,
Barcelona, Spain
11:05 AM
Panel Discussion
11:25 AM

Coffee Break

Session II: Biliary Tract Cancers
Moderated by: Arndt Vogel

11:45 AM
Stratified Treatment Concepts in Metastatic CCA

CN

Cindy Neuzillet
Institut Curie, Paris, France
12:05 PM
Neoadjuvant Treatment Approaches

AH

Antoine Hollebecque
Gustave Roussy Institute, Villejuif, France
12:25 PM
Emerging Targets in CCA
Arndt-Vogel-1
Arndt Vogel
Hannover Medical School, Germany
12:45 PM
Panel Discussion
01:05 PM
Lunch Break + Faculty and Fellow Photo

Session III: Hepatocellular Cancer
Moderated by: Lorenza Rimassa

01:55 PM
Potential Role of Immunotherapy in Earlier Stages
Michel-Ducreux
Michel Ducreux
Gustave Roussy Institute, Villejuif, France
02:15 PM
Immunotherapy Combinations in Advanced/Met HCC
Arndt-Vogel-1
Arndt Vogel
Hannover Medical School, Germany
02:35 PM
Sequential Treatment of mHCC
Lorenza-Rimassa
Lorenza Rimassa
IRCCS Humanitas Research Hospital, Milan, Italy
02:55 PM
Panel Discussion
03:15 PM
Coffee Break

Session IV: Neuroendocrine Tumors
Moderated by: Michel Ducreux

03:35 PM
Strategy of Treatment of NET
Marianne-Pavel
Marianne Pavel
Friedrich-Alexander University of Erlangen, Germany
03:55 PM
Neuroendocrine Carcinoma Treatment

JH

Julien Hadoux
Gustave Roussy Institute, Villejuif, France
04:15 PM
Panel Discussion
04:35 PM
Adjourn

September 12, 2026 | Day 1  

08:00 AM
Registration Opens
08:45 AM
Coffee Break

Session V: Esophagogastric Cancer
Moderated by: Gerald Prager

09:05 AM
Perioperative Treatment Options of Gastric Cancer
Elizabeth-Smyth
Elizabeth Smyth
University of Oxford, UK
09:25 AM
How to Stratify First-Line Treatment in mGC According to the Molecular Profile
Lorenzen Sylvie (3)
Sylvie Lorenzen
Klinikum Rechts der Isar, Technical University Munich, Germany
09:45 AM
Panel Discussion
10:05 AM
Coffee Break

Session VI: Metastatic Colorectal Cancer
Moderated by: Tanios Bekaii-Saab

10:25 AM
Plenary Presentation: Novel Treatment Approaches in mCRC
Tanios-Saab
Tanios Bekaii-Saab
Mayo Clinic, Phoenix, AZ
10:45 AM
IOs in dMMR/MSS mCRC
Thierry-Andre
Thierry André
Hospital Saint-Antoine, Ap-Hp Sorbonne
University, Paris, France
11:05 AM
Who Still Benefits From (m)FOLFIRINOX
Gerald-Prager
Gerald Prager
Medical University of Vienna, Austria
11:25 AM
Panel Discussion
11:45 AM
Lunch Break + Faculty and Fellow Photo

Session VII: Early-Stage and Oligometastatic CRC
Moderated by: Jenny Seligmann

12:35 PM
Organ Preservation in Rectal Cancer

AdH

Andre d’Hoore
KU Leuven, Belgium
12:55 PM
IOs Neoadjuvant or Adjuvant in Early Stage Colon Cancer?

JS

Jenny Seligmann
University of Leeds, UK
01:15 PM
ctDNA Guided Adjuvant Treatment in Resected CRC

GF

Gunnar Folprecht
University Hospital Carl Gustav Carus, Dresden, Germany
01:35 PM
Panel Discussion
01:55 PM
Coffee Break

Session VII: Rare GI Tumors
Moderated by: Eric Van Cutsem

02:15 PM
Immunotherapy Treatment Combinations in Metastatic Anal Canal Cancers
Sheela-Rao
Sheela Rao
Royal Marsden NHS Foundation Trust,
London, UK
02:35 PM
Systemic Treatment in Small Intestine Carcinoma

TA

Thomas Aparicio
Assistance Publique, Hôpitaux de Paris (AP-HP), France
02:55 PM
Hereditary Syndromes in GI Cancer and How to Screen
eric-van-cutsem
Eric Van Cutsem
KU Leuven, Belgium
03:15 PM
Panel Discussion
03:35 PM
Adjourn

Alex Worthington
Project Manager

How long has Alex Worthington been in the business?

Alex Worthington has been with MD Education since 2024

About Alex Worthington

As Assistant Project Manager, I work to ensure the Smooth running of events, assisting in the search process, outreach, organization, and the maintenance of any event. Having a Diverse Career background Working around the world, I pride myself on networking and creating positive relationships seamlessly with all attendees.

Alex-Worthington 2